At Gene2Lead, we incorporate AI-based computational pipelines to existing medicinal chemistry-based drug discovery programs. We are developing an AI-integrated platform technology that unmasks difficult drug targets and generates therapeutics against them, revealing high-value and previously inaccessible biomolecule targets that can potentially be applied to a range of diseases. Our platform offers drug discovery programs with comprehensive structural insights for identifying druggable binding sites protein protein-analyzing ligand binding modes and computationally generating rational drug design ideas in a robust scale-up and expedited fashion. We receive client projects at the level of a target gene of interest and work it through a semi-automated customized high throughput project pipeline to identify novelty lead drug molecules for experimental testing.